LEVOLEUCOVORIN (has an active metabolite) | LEVOLEUCOVORIN LEUCOVORIN | ATC B03AD04 ATC B03AD01 ATC B03AD02 ATC B03AD05 ATC B03AD03 ATC B03BB01 ATC V04CX02 ATC B03BB51 ATC B03AE02 ATC B03AE01
VARIOUS ANTIANEMIC ANTIDOTE TO FOLIC ACID ANTAGONISTS ANTINEOPLASTIC ADJUNCTS RESCUE AFTER HIGH-DOSE METHOTREXATE THERAPY IN OSTEOSARCOMA USE IN COMBINATION CHEMOTHERAPY WITH 5-FLUOROURACIL RAPIDLY ABSORBED AND ENTERS THE GENERAL BODY POOL OF REDUCED FOLATES CONVERTED TO 5-METHYLTETRAHYDROFOLIC ACID (5-METHYL-THF) | INJECTION ORAL INTRAVENOUS | VD 16.2 LITER (65 KILOGRAM) PPB 91 PERCENT Cl 22.6 LITER / HOUR (65 KILOGRAM) HT 1.3 HOUR SOLUBILITY SOLUBLE IN WATER | PDB 3UWL (CRYSTAL STRUCTURE OF ENTEROCCOCUS FAECALIS THYMIDYLATE SYNTHASE (EFTS) IN COMPLEX WITH 5-FORMYL TETRAHYDROFOLATE) LIGAND CODE = FOZ (link to the list of PDB complexes) Download experimental 3D coordinates of FOZ with added hydrogens | Unknown more at DrugCentral | EMA ANSM (in French) Inxight Drugs Dailymed Drugs.com SIDER side effects Chemical Probes Portal ChEMBL BindingDB DrugBank |